Literature DB >> 18241329

Acute syphilitic chorioretinitis after a missed primary diagnosis: a case report.

Claudia Handtrack1, Harald Knorr, Kerstin U Amann, Christoph Schoerner, Karl F Hilgers, Walter Geissdörfer.   

Abstract

INTRODUCTION: Syphilis is well known as an infectious disease which can present with a large variety of symptoms. Clinical diagnosis can be difficult and may be complicated in modern medicine by immunosuppressive treatment and possible side effects of medication. CASE
PRESENTATION: We describe a rare case of placoid chorioretinitis due to Treponema pallidum which developed after the primary symptom of proteinuria was not recognized as a rare manifestation of syphilis. Diagnosis of syphilitic chorioretinitis and/or endophthalmitis was made by broad range amplification of the bacterial 16S ribosomal RNA gene obtained from vitreous after diagnostic vitrectomy.
CONCLUSION: This case shows that clinicians should be alert in patients with proteinuria and chorioretinitis as they can represent rare manifestations of syphilis. Syphilis should be in the differential diagnosis of any unknown symptom and in the presumed side effects of medication.

Entities:  

Year:  2008        PMID: 18241329      PMCID: PMC2248591          DOI: 10.1186/1752-1947-2-33

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  13 in total

1.  Diagnosis of Treponema pallidum in vitreous samples using real time polymerase chain reaction.

Authors:  M S Rajan; P Pantelidis; C Y W Tong; G L French; E M Graham; M R Stanford
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 2.  Update on syphilis: resurgence of an old problem.

Authors:  Matthew R Golden; Christina M Marra; King K Holmes
Journal:  JAMA       Date:  2003-09-17       Impact factor: 56.272

3.  Syphilis--a reversible cause of nephrotic syndrome in HIV infection.

Authors:  D J Kusner; J J Ellner
Journal:  N Engl J Med       Date:  1991-01-31       Impact factor: 91.245

4.  Acute syphilitic posterior placoid chorioretinitis.

Authors:  J D Gass; R A Braunstein; R G Chenoweth
Journal:  Ophthalmology       Date:  1990-10       Impact factor: 12.079

5.  A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group.

Authors:  R T Rolfs; M R Joesoef; E F Hendershot; A M Rompalo; M H Augenbraun; M Chiu; G Bolan; S C Johnson; P French; E Steen; J D Radolf; S Larsen
Journal:  N Engl J Med       Date:  1997-07-31       Impact factor: 91.245

6.  Detection of Treponema pallidum in the vitreous by PCR.

Authors:  M Müller; I Ewert; F Hansmann; C Tiemann; H J Hagedorn; W Solbach; J Roider; B Nölle; H Laqua; H Hoerauf
Journal:  Br J Ophthalmol       Date:  2006-11-15       Impact factor: 4.638

7.  Corticosteroid-induced modulation of acute syphilitic posterior placoid chorioretinitis.

Authors:  Maryam Zamani; Richard A Garfinkel
Journal:  Am J Ophthalmol       Date:  2003-06       Impact factor: 5.258

8.  Central nervous system infection in congenital syphilis.

Authors:  Ian C Michelow; George D Wendel; Michael V Norgard; Fiker Zeray; N Kristine Leos; Rajiha Alsaadi; Pablo J Sánchez
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

9.  Renal disease and syphilis: a report of nephrotic syndrome with minimal change disease.

Authors:  N K Krane; P Espenan; P D Walker; S M Bergman; J D Wallin
Journal:  Am J Kidney Dis       Date:  1987-02       Impact factor: 8.860

10.  Syphilitic uveitis in patients infected with human immunodeficiency virus.

Authors:  Thi Ha Chau Tran; Nathalie Cassoux; Bahram Bodaghi; Christine Fardeau; Eric Caumes; Phuc Lehoang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-15       Impact factor: 3.535

View more
  1 in total

1.  Visual evoked potential (VEP) and multifocal electroretinogram (mfERG) in ocular syphilitic posterior segment inflammation.

Authors:  Philip Alexander; Yaqin Wen; Julia M Baxter; Naing L Tint; Andrew C Browning; Winfried M Amoaku
Journal:  Doc Ophthalmol       Date:  2012-06-23       Impact factor: 2.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.